PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29135083-0	2018	Comparison of the anticancer properties of a novel valproic acid prodrug to leading histone deacetylase inhibitors.	Valproic Acid	51-64	histone deacetylase 9	Homo sapiens	84-103	
29135083-1	2018	The HDAC inhibitory activity of valproic acid (VPA) has led to on-going evaluation of it as an anticancer agent.	Valproic Acid	32-45	histone deacetylase 9	Homo sapiens	4-8	
29135083-1	2018	The HDAC inhibitory activity of valproic acid (VPA) has led to on-going evaluation of it as an anticancer agent.	Valproic Acid	47-50	histone deacetylase 9	Homo sapiens	4-8	
29135083-2	2018	The histone deacetylase (HDAC) inhibitor AN446, a prodrug of VPA, releases the acid upon metabolic degradation.	Valproic Acid	61-64	histone deacetylase 9	Homo sapiens	4-23	
29135083-2	2018	The histone deacetylase (HDAC) inhibitor AN446, a prodrug of VPA, releases the acid upon metabolic degradation.	Valproic Acid	61-64	histone deacetylase 9	Homo sapiens	25-29